Pharmaceuticals

Cedrus Group's Chairman Mr. Rani Jarkas Invited to Speak at the ANNUAL BIOPHARMA DEVELOPMENT AND PRODUCTION WEEK

HONG KONG, Sept. 1, 2020 /PRNewswire/ -- The Chairman of Cedrus Group ("Cedrus") , Mr. Rani Jarkas, is invited to speak at the"6th Annual Biopharma Development and Production Week" conference to be held on 3rd - 5th November 2020. This year, the event will be ...

2020-09-01 09:00 5138

Viva Biotech Announced 2020 Interim Results

Financial Highlights for the 6 months ended June 30, 2020 * Revenue amounted to RMB197.6 million, representing a YOY increase of 38.9% * Gross profit amounted to RMB100.1 million, representing a YOY increase of 39.2%, with Gross profit margin of 50.7% * Adjusted net profit rose to RMB123.7 m...

2020-08-31 23:27 7407

Harbour BioMed Will Present Its New Platform HBICE (Heavy chain only antibody (HCAb) Based Immune Cell Engager) at 16th PEGS Boston Summit

SHANGHAI, Aug. 31, 2020 /PRNewswire/ -- Harbour BioMed, a global, clinical-stage, innovative biopharmaceutical company, today announced that it presented  its newly developed  HBICETM (HCAb Based Immune Cell Engager) platform and its ability to generate fast and reliable next-generation bispecif...

2020-08-31 21:39 4520

CStone Receives US FDA IND Clearance for CS1001-201 Study to Evaluate Anti-PD-L1 Monoclonal Antibody Sugemalimab Monotherapy in R/R ENKTL

SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- CStone Pharmaceuticals (SUZHOU) Co., Ltd. ("CStone", HKEX: 2616) today announced that the US Food and Drug Administration (FDA) has completed their review of the Investigational New Drug (IND) application for anti-PD-L1 monoclonal antibody sugemalimab ...

2020-08-31 11:35 3887

GenScript Reports 2020 Interim Results and Provides Business Update

NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, today reported interim results for the six months endedJune 30, 2020 and provided a corporate update. Revenue of the Group for the six months endedJune 30, 2020 was...

2020-08-31 11:32 11971

Genesis MedTech Acquires World-first Drug-coated Balloon Technology with Next-generation Angioplasty Architecture for the Treatment of Peripheral Vascular Diseases

SINGAPORE, Aug. 31, 2020 /PRNewswire/ -- Genesis MedTech International has completed the acquisition of the Chocolate Touch ® drug-coated balloon (DCB), a drug-device technology asset from TriReme Medical LLC, a wholly-owned subsidiary ofSingapore-listed QT Vascular Ltd, which engages in the desi...

2020-08-31 09:00 10827

Dr Ivan Puah, Medical Director Of Amaris B. Clinic, Discovers The Main Period Men Between 35 And 50 Year-olds First Experience Gynecomastia in Singapore

SINGAPORE, Aug. 28, 2020 /PRNewswire/ -- Dr Ivan Puah, Medical Director of Amaris B. Clinic, is accredited by the Ministry of Health to perform surgical body sculpting procedures such as liposuction. Amaris B. Clinic is one of the few medical clinics inSingapore to offer gynecomastia and is an...

2020-08-28 07:16 4340

Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone

Approval issued to file new drug application for SIR-Spheres® Y-90 resin microspheres inChina based on existing clinical trial data. WOBURN, Mass., Aug. 27, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that Sirtex and ...

2020-08-27 20:30 3762

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

SINGAPORE, Aug. 27, 2020 /PRNewswire/ -- Concept Medical Inc ., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in theFUTURE BTK trial (Randomized Controlled Trial of First SirolimUs CoaTed Balloon VersUs S...

2020-08-27 18:16 4294

Ascentage Pharma Releases Preclinical Results of IAP Antagonist APG-1387 in an Oral Presentation at EASL ILC 2020

SUZHOU, China and ROCKVILLE, Md., Aug. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that preclinical study resul...

2020-08-27 18:10 5354

Innovent Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Progress

SAN FRANCISCO, U.S. and SUZHOU, China, Aug. 27, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other ma...

2020-08-27 09:37 10649

Digital International Liver Congress: Alcohol cravings could be reduced by changing gut microbiota, new study reveals

GENEVA, Aug. 27, 2020 /PRNewswire/ -- The importance of gut microbiota in reducing the burden of alcohol-related liver disease and liver cancer has been demonstrated in a novel pilot study presented at The Digital International Liver Congress™ 2020. The study examined whether the transfer of fec...

2020-08-27 06:01 4171

CSPC Pharmaceutical Announces 2020 Interim Results

Profit Attributable To Shareholders Increased 23.2% to RMB2,314 Million Declared An Interim Dividend of HK6 Cents Per Share Proposed A Bonus Issue of 3 Bonus Shares For Every 5 Existing Shares Held HONG KONG, Aug. 26, 2020 /PRNewswire/ -- CSPC Pharmaceutical Group Limited (HKEx: 01093) ("CSPC P...

2020-08-26 12:30 8035

Duke-NUS to Join the TriNetX Network

CAMBRIDGE, Massachusetts, Aug. 26, 2020 /PRNewswire/ -- Duke-NUS, the only graduate-entry medical school inSingapore, has joined the TriNetX global research network to increase clinical trial adoption and to facilitate better collaboration with other global healthcare organizations (HCOs). This l...

2020-08-26 08:00 2694

EpiVax Announces Licensing of COVID-19 Vaccine Candidate to EpiVax Therapeutics

PROVIDENCE, R.I., Aug. 25, 2020 /PRNewswire/ -- EpiVax, Inc. ("EpiVax"), a Rhode Island-based company and recognized leader in the field of computational vaccinology, today announced it has out-licensed its COVID-19 vaccine candidate, EPV-CoV-19, to EpiVax Therapeutics ("EVT"), aNew York-based co...

2020-08-25 23:35 3384

AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab

SEATTLE, Aug. 25, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), achieved the on-schedule completion of a drug substance Process Performance Qualification (PPQ) campaign, focused on teplizumab  (PRV-031) for partn...

2020-08-25 22:00 5815

FDA Accepts Filing of New Drug Application for Tepotinib for the Treatment of Patients with Metastatic NSCLC with METex14 Skipping Alterations

- Tepotinib granted Priority Review and is being evaluated under FDA Real-Time Oncology Review (RTOR) pilot program - Tepotinib is a highly targeted inhibitor of c-MET that is administered as a once-daily oral tablet - Data show robust, consistent and durable clinical response across different ...

2020-08-25 21:22 2706

Connect Biopharma Completes $115 Million Series C Financing to Advance Ongoing Clinical Trials in Atopic Dermatitis and Ulcerative Colitis and Initiate Additional Clinical Programs

- In an oversubscribed round, top-tier investors provide significant financial resources to accelerate clinical development of potentially best-in-class therapies for inflammatory/autoimmune diseases - SAN DIEGO and TAICANG, SUZHOU, China, Aug. 24, 2020 /PRNewswire/ -- Connect Biopharma ("Connec...

2020-08-24 20:00 9212

Harbour BioMed Signs Strategic Collaboration Agreement with Vir Biotechnology to Develop Novel Therapies for Immuno-Oncology and Infectious Diseases

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Aug. 24, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company today announced that it has entered into a strategic collaboration with Vir Biotechnology (Nasdaq: VIR), a clinical-stage immunology...

2020-08-24 19:00 3656

PharmaSources.com to Help Propel the Chinese API Export Business with E-Trade Session CPhI China Top API Exporters & Products

SHANGHAI, Aug. 24, 2020 /PRNewswire/ -- PharmaSources.com, the vertical B2B portal for the pharmaceutical industry, announces the launch of the virtual session CPhI China Top API Exporters & Products on24-28 August 2020, as part of the CPhI & P-MEC China E-Trade Season (August toOctober 2020). ...

2020-08-24 16:58 3353
1 ... 170171172173174175176 ... 189